RETRACTED ARTICLE: A new Er(III)-based MOF showing anti-colon cancer activity by inhibiting IL-6-STAT3 signaling pathway and reducing TNF-α and IL-1β production

Abstract

We, the Editors and Publisher of the Journal of Coordination Chemistry, have retracted the following article:

Changwei Lv, Yanwu Liu, Guolin Meng, Jing Li & Zhenyu Ti. A new Er(III)-based MOF showing anti-colon cancer activity by inhibiting IL-6-STAT3 signaling pathway and reducing TNF-α and IL-1β production, Journal of Coordination Chemistry; 2020, VOL. 73, NO. 9, 1478–1489. DOI: 10.1080/00958972.2020.1780216

Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:

Statement of Retraction: A new Er(III)-based MOF showing anti-colon cancer activity by inhibiting IL-6-STAT3 signaling pathway and reducing TNF-α and IL-1β production